NARA Discovery
Article Details
← Back to Search Results
Journal Article

Pseudomonas fluorescens orchestrates a fine metabolic‐balancing act to counter aluminium toxicity

Joseph Lemire; Ryan Mailloux; Christopher Auger; Daniel Whalen; Vasu D. Appanna
Environmental Microbiology · Vol. 12, Issue 6 · pp. 1384-1390 · 2010

Abstract

Summary Aluminium (Al), an environmental toxin, is known to disrupt cellular functions by perturbing iron (Fe) homeostasis. However, Fe is essential for such metabolic processes as the tricarboxylic acid (TCA) cycle and oxidative phosphorylation, the two pivotal networks that mediate ATP production during aerobiosis. To counter the Fe conundrum induced by Al toxicity, Pseudomonas fluorescens utilizes isocitrate lyase and isocitrate dehydrogenase‐NADP dependent to metabolize citrate when confronted with an ineffective aconitase provoked by Al stress. By invoking fumarase C, a hydratase devoid of Fe, this microbe is able to generate essential metabolites. To compensate for the severely diminished enzymes like Complex I, Complex II and Complex IV, the upregulation of a H 2 O‐generating NADH oxidase enables the metabolism of citrate, the sole carbon source via a modified TCA cycle. The overexpression of succinyl‐CoA synthetase affords an effective route to ATP production by substrate‐level phosphorylation in the absence of O 2 . This fine metabolic balance enables P. fluorescens to survive the dearth of bioavailable Fe triggered by an Al environment, a feature that may have potential applications in bioremediation technologies.

Bibliographic Information

JournalEnvironmental Microbiology
PublisherWiley
Publication Date2010-06-01
Publication Year2010
Volume12
Issue6
Pages1384-1390
Document TypeJournal Article
Print ISSN1462-2912
eISSN1462-2920
DOI10.1111/j.1462-2920.2010.02200.x
SubjectMicrobial Ecology

Access Information

NARA Access Coverage1999-01-01~Current
Journal Homepagehttps://onlinelibrary.wiley.com/loi/14622920
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.